VIASYS Healthcare, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From VIASYS Healthcare, Inc.
ARM counts $14.1bn in fundraising in the first half of 2021, up 35% from mid-year 2020. Also, Chinese mRNA players Abogen raises a $700m series C venture capital round, Pfizer prices a $1bn sustainability bond and while IPOs slow in the US, China and South Korea see new first-time offerings.
Forrest Bird, inventor of mechanical ventilators and a respirator known as the “BabyBird” for pediatric uses, and founder of Bird Medical Technologies Inc., passed away Aug. 2 at age 94. His initial respirators and ventilators were bought out and improved upon over the last 40 years by a series of device firms.
The current specialty-dominated care paradigm for sleep apnea can't scale-up to meet the demands of an enormous and serious chronic disease. New companies help move diagnosis and treatment to the physicians that see patients first.
Over the last three years, deal values in medical device M&A have hit all time highs, with more big deals done than ever before. Still, even with deal values soaring, device M&A remains a small-stakes game. IN VIVO looks at dealmaking in medtech by therapeutic and industry segments.
- In Vitro Diagnostics
- Implantable Devices
- Monitoring Equipment & Devices